Cargando…

Vaccinia Virus Induces Programmed Necrosis in Ovarian Cancer Cells

The mechanisms by which oncolytic vaccinia virus induces tumor cell death are poorly understood. We have evaluated cell death pathways following infection of ovarian cancer cells with both wild-type and thymidine kinase-deleted (dTK) Lister strain vaccinia. We show that death does not rely upon clas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whilding, Lynsey M, Archibald, Kyra M, Kulbe, Hagen, Balkwill, Frances R, Öberg, Daniel, McNeish, Iain A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831043/ https://www.ncbi.nlm.nih.gov/pubmed/23985697 http://dx.doi.org/10.1038/mt.2013.195

Ejemplares similares

Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium
por: Archibald, Kyra M, et al.
Publicado: (2012)

“Re-educating” tumor-associated macrophages by targeting NF-κB
por: Hagemann, Thorsten, et al.
Publicado: (2008)

p21 promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker
por: Flak, Magdalena B, et al.
Publicado: (2010)

The peritoneal tumour microenvironment of high-grade serous ovarian cancer
por: Leinster, D Andrew, et al.
Publicado: (2012)

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer
por: Ingemarsdotter, C K, et al.
Publicado: (2010)

Endothelial cell junctional adhesion molecule C plays a key role in the development of tumors in a murine model of ovarian cancer
por: Leinster, David A., et al.
Publicado: (2013)

Strategies to Optimise Oncolytic Viral Therapies: The Role of Natural Killer Cells
por: Leung, Elaine Y. L., et al.
Publicado: (2021)

Oncologist-led BRCA ‘mainstreaming’ in the ovarian cancer clinic: A study of 255 patients and its impact on their management
por: Rumford, Megan, et al.
Publicado: (2020)

Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer
por: McGivern, Niamh, et al.
Publicado: (2017)

Targeted anti-vascular therapies for ovarian cancer: current evidence
por: Hall, M, et al.
Publicado: (2013)

CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus
por: Elmetwali, Taha, et al.
Publicado: (2010)

The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality
por: Bray, Chandler, et al.
Publicado: (2023)

Vaccinia Virus Induces Rapid Necrosis in Keratinocytes by a STAT3-Dependent Mechanism
por: He, Yong, et al.
Publicado: (2014)

Synergy between liposomal zoledronic acid and γδ T-cells in the treatment of epithelial ovarian cancer
por: Pereira, Ana Catarina Parente, et al.
Publicado: (2013)

Practical guidance for the management of side effects during rucaparib therapy in a multidisciplinary UK setting
por: Tookman, Laura, et al.
Publicado: (2020)

Replication-inducible vaccinia virus vectors with enhanced safety in vivo
por: O’Connell, Caitlin M., et al.
Publicado: (2020)

Mechanisms of diarrhoea
por: Booth, I.W., et al.
Publicado: (1993)

Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells
por: Kulbe, Hagen, et al.
Publicado: (2016)

Attenuation of Vaccinia Virus
por: Yakubitskiy, S. N., et al.
Publicado: (2015)

Vaccinia and Pox-Virus
por: Chalikonda, Sricharan, et al.
Publicado: (2007)

Editorial: Rising stars in vascular physiology: 2022
por: Tulis, David A., et al.
Publicado: (2023)

Risk Factors for Ovarian Cancer: An Umbrella Review of the Literature
por: Whelan, Eilbhe, et al.
Publicado: (2022)

Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10
por: Colomban, Olivier, et al.
Publicado: (2023)

NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer
por: Leung, Elaine Y.L., et al.
Publicado: (2020)

Enhancing the Immunogenicity of Vaccinia Virus
por: Shchelkunov, Sergei N., et al.
Publicado: (2022)

Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in cancer
por: Coley, Helen M., et al.
Publicado: (2012)

Vaccinia Virus in Household Environment during Bovine Vaccinia Outbreak, Brazil
por: Assis, Felipe L., et al.
Publicado: (2013)

Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries
por: Limbu, Roshan, et al.
Publicado: (2018)

THE CULTIVATION OF THE GRANULES OF VACCINIA VIRUS
por: Craciun, E. C., et al.
Publicado: (1926)

MORPHOLOGICAL STRUCTURE OF THE VIRUS OF VACCINIA
por: Green, R. H., et al.
Publicado: (1942)

CENTRIFUGE EXPERIMENTS WITH THE VIRUS OF VACCINIA
por: Tang, F. F.
Publicado: (1930)

Brazilian Vaccinia Viruses and Their Origins
por: Trindade, Giliane S., et al.
Publicado: (2007)

Lack of Transmission of Vaccinia Virus
por: Stark, James H., et al.
Publicado: (2006)

Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor.
por: Malik, S. T., et al.
Publicado: (1992)

Regulation of K(Ca)2.3 and endothelium-dependent hyperpolarization (EDH) in the rat middle cerebral artery: the role of lipoxygenase metabolites and isoprostanes
por: Gauthier, Kathryn M., et al.
Publicado: (2014)

A vaccinia virus renaissance: New vaccine and immunotherapeutic uses after smallpox eradication
por: Verardi, Paulo H., et al.
Publicado: (2012)

CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity
por: Walton, Josephine B., et al.
Publicado: (2017)

INDUCTION OF SKIN RESISTANCE TO VACCINIA VIRUS IN RABBITS BY VACCINIA-SOLUBLE EARLY ANTIGENS
por: Ueda, Y., et al.
Publicado: (1973)

Building invitro 3D human multicellular models of high-grade serous ovarian cancer
por: Malacrida, Beatrice, et al.
Publicado: (2022)

Safe administration of chemotherapy in mast cell activation syndrome
por: Lythgoe, MP, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2hor96teffupqklm11at53ftji